Is PSB or MRK a better dividend investment in 2026?

PSB currently yields 31.63% with a 5% 5-year dividend growth rate. MRK yields 3.25% with 8.2% growth. The better choice depends on your goal: PSB offers higher current income.

What is the dividend yield difference between PSB and MRK?

PSB has a forward dividend yield of 31.63% ($59.28/share annually). MRK yields 3.25% ($3.08/share annually). The yield gap is 28.38 percentage points.

Home › Compare › PSB vs MRK

PSB vs MRK: Dividend Comparison 2026

PSB yields 31.63% · MRK yields 3.25%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 PSB wins by $237.60M in total portfolio value

INVESTMENT

TIME HORIZON10 years

PSB

● Live price

31.63%

Share price

$187.44

Annual div

$59.28

5Y div CAGR

40%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$237.63M

Annual income

$195,574,432.80

Full PSB calculator →

MRK

Merck & Co. Inc.

● Live price

3.25%

Share price

$94.80

Annual div

$3.08

5Y div CAGR

8.2%

Payout ratio

42%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.7K

Annual income

$950.29

Full MRK calculator →

Portfolio growth — PSB vs MRK

📍 PSB pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	PSB	MRK
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, PSB + MRK cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

PSB pays

MRK pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PSB

Annual income on $10K today (after 15% tax)

$2,688.22/yr

After 10yr DRIP, annual income (after tax)

$166,238,267.88/yr

MRK

Annual income on $10K today (after 15% tax)

$276.16/yr

After 10yr DRIP, annual income (after tax)

$807.75/yr

At 15% tax rate, PSB beats the other by $166,237,460.13/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PSB + MRK for your $10,000?

PSB: 50%MRK: 50%

100% MRK50/50100% PSB

Portfolio after 10yr

$118.83M

Annual income

$97,787,691.55/yr

Blended yield

82.29%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

PSB

Analyst Ratings

Buy

Hold

Sell

Consensus: Hold

MRK

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$128.54

+35.6% upside vs current

Range: $100.00 — $150.00

Altman Z

4.0

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PSB buys

MRK buys

No recent congressional trades found for PSB or MRK in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricPSBMRK

Forward yield	31.63% ✓	3.25%
Annual dividend / share	$59.28 ✓	$3.08
Payout ratio	50%	42% ✓
1-year div growth	0%	5.5% ✓
5-year div CAGR	40% ✓	8.2%
Portfolio after 10y	$237.63M ✓	$30.7K
Annual income after 10y	$195,574,432.80 ✓	$950.29
Total dividends collected	$234.09M ✓	$6.1K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare
Analyst consensus	Hold	Buy

Year-by-year: PSB vs MRK ($10,000, DRIP)

Year	PSB Portfolio	PSB Income/yr	MRK Portfolio	MRK Income/yr	Gap
1← crossover	$15,128	$4,427.66	$11,192	$351.54	+$3.9K → PSB
2	$24,950	$8,763.75	$12,524	$392.70	+$12.4K → PSB
3	$45,609	$18,912.07	$14,015	$438.65	+$31.6K → PSB
4	$94,035	$45,233.13	$15,682	$489.96	+$78.4K → PSB
5	$222,639	$122,022.25	$17,547	$547.23	+$205.1K → PSB
6	$616,229	$378,004.70	$19,632	$611.16	+$596.6K → PSB
7	$2,028,296	$1,368,930.84	$21,963	$682.53	+$2.01M → PSB
8	$8,065,700	$5,895,423.72	$24,571	$762.18	+$8.04M → PSB
9	$39,304,276	$30,673,977.05	$27,486	$851.08	+$39.28M → PSB
10	$237,630,008	$195,574,432.80	$30,745	$950.29	+$237.60M → PSB

PSB vs MRK: Complete Analysis 2026

PSB — Stock

PS Business Parks, Inc., a member of the S&P MidCap 400, is a REIT that acquires, develops, owns, and operates commercial properties, primarily multi-tenant industrial, flex, and office space. As of September 30, 2020, the Company wholly owned 27.5 million rentable square feet with approximately 5,000 commercial customers in six states. The Company also held a 95.0% interest in a 395-unit apartment complex and a 98.2% interest in a development of a 411-unit multifamily apartment complex.

Full PSB Calculator →

MRK — Healthcare

Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.

Full MRK Calculator →

📬

Get this PSB vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PSB vs SCHD PSB vs JEPI PSB vs O PSB vs KO PSB vs MAIN PSB vs JNJ PSB vs ABBV PSB vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.